CryoPatch® SG
CryoLife receives FDA 510(k) clearance for SynerGraft processed human cardiac patch material.Learn more
CryoLife receives FDA 510(k) clearance for SynerGraft processed human cardiac patch material.Learn more
CryoLife preserved tissues have dramatically improved and enhanced the lives of tens of thousands of patients. Learn more


CryoLife is a contemporary biological medical device company that, since its founding in 1984, has been focused on the development of implantable biological devices, surgical adhesives, and biomaterials for use in cardiac and vascular reconstruction for patients of all ages.